630384-20-2

Usage

InChI:InChI=1/C9H10IN/c10-8-3-1-7(2-4-8)9(11)5-6-9/h1-4H,5-6,11H2

Upstream product

• 630384-19-9 tert-butyl (1-(4-iodophenyl)cyclopropyl)carbamate 
• 3058-39-7 4-iodobenzonitrile 
• 925-90-6 ethylmagnesium bromide 

Downstream Products

• 630384-21-3 1-[1-(4-iodophenyl)cyclopropyl]-pyrrolidin-2-one 
• 890172-54-0 N-[1-(4-Iodophenyl)cyclopropyl]methanesulphonamide 
• 858677-84-6 1-[1-(4-iodo-phenyl)cyclopropyl]-4-methyl-piperidine 

Relevant academic research and scientific papers

New benzothiazine and benzothiadiazine compounds

The invention relates to compounds of formula (I): wherein R1 represents hydrogen, alkyl or cycloalkyl, R2 represents hydrogen, halogen or hydroxy, A represents CR3R4 or NR3 wherein R3 and

3-(4-PIPERIDINE-1YLMETHYL-PHENYL)-PROPION ACID-PHENYLAMIDE-DERIVATIVES AND RELATED COMPOUNDS USED IN THE FORM OF MCH ANTAGONISTS (MELANINE CONCENTRATING HORMONE) FOR TREATING EATING DISORDERS

The invention relates to amid compounds of general formula (I), wherein groups and residuals A, B, b, W, X, Y, Z, R1, R2 and R3 have significances given in a claim 1. In addition, said invention relates to drugs containing at least one type of inventive amid. Because of the antagonist activity of an MCH-receptor, the inventive drugs are suitable for treating metabolic disturbances and/or eating disorders, in particular adiposity, bulimia, anorexia, hyperphagia and diabetes.

1,1-DISUBSTITUTED CYCLOALKYL DERIVATIVES AS FACTOR XA INHIBITORS

The present application describes 1,1-disubstituted cycloalkyl compounds and derivatives thereof, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of factor Xa.